Who are OnabotulinumtoxinA 100 UNT [Botox]'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Botulinum toxin A "Botox Cosmetics", Botox infiltration, BOTULINUM TOXIN TYPE B, powder BoNT-A (BOTOX/Vistabel), Onabotulinumtoxin A (BoNT), Botulinum Toxin-A injection.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/onabotulinumtoxina-100-unt-botox.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

OnabotulinumtoxinA 100 UNT [Botox] — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

OnabotulinumtoxinA 100 UNT [Botox] (OnabotulinumtoxinA 100 UNT [Botox]) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Neurotoxin; botulinum toxin type A. Area: Neurology; Dermatology; Aesthetics.

marketed Neurotoxin; botulinum toxin type A SNAP-25 (synaptosome-associated protein of 25 kDa) Neurology; Dermatology; Aesthetics Small molecule Live · refreshed every 30 min

Target snapshot

OnabotulinumtoxinA 100 UNT [Botox] (OnabotulinumtoxinA 100 UNT [Botox]) — Women and Infants Hospital of Rhode Island. OnabotulinumtoxinA blocks the release of acetylcholine at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
OnabotulinumtoxinA 100 UNT [Botox] TARGET	OnabotulinumtoxinA 100 UNT [Botox]	Women and Infants Hospital of Rhode Island	marketed	Neurotoxin; botulinum toxin type A	SNAP-25 (synaptosome-associated protein of 25 kDa)
Botulinum toxin A "Botox Cosmetics"	Botulinum toxin A "Botox Cosmetics"	Croma-Pharma GmbH	marketed	Neurotoxin; acetylcholine release inhibitor	SNARE complex (synaptosome-associated protein); acetylcholine release machinery
Botox infiltration	Botox infiltration	University Rovira i Virgili	marketed	Neurotoxin; botulinum toxin type A	SNARE complex (synaptosome-associated protein); acetylcholine release machinery
BOTULINUM TOXIN TYPE B	BOTULINUM TOXIN TYPE B	Eisai Co., Ltd.	marketed	Neurotoxin; botulinum toxin	Synaptobrevin (VAMP)
powder BoNT-A (BOTOX/Vistabel)	powder BoNT-A (BOTOX/Vistabel)	Galderma R&D	marketed	Neurotoxin; botulinum toxin type A	SNAP-25 (synaptosome-associated protein of 25 kDa)
Onabotulinumtoxin A (BoNT)	Onabotulinumtoxin A (BoNT)	Edgar LeClaire, MD	marketed	Neurotoxin; botulinum toxin serotype A	SNAP-25 (synaptosome-associated protein of 25 kDa)
Botulinum Toxin-A injection	Botulinum Toxin-A injection	Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust	marketed	Neurotoxin; neuromuscular blocking agent	SNARE complex (specifically cleaves SNAP-25)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Neurotoxin; botulinum toxin type A class)

Galderma R&D · 1 drug in this class
The Methodist Hospital Research Institute · 1 drug in this class
University Hospital, Clermont-Ferrand · 1 drug in this class
University Rovira i Virgili · 1 drug in this class
Women and Infants Hospital of Rhode Island · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). OnabotulinumtoxinA 100 UNT [Botox] — Competitive Intelligence Brief. https://druglandscape.com/ci/onabotulinumtoxina-100-unt-botox. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab